Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 936 Records) |
Query Trace: Lung Neoplasms and Kras[original query] |
---|
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients. Cancers 2023 9 15 (18): . Lisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, Sara Raimondi, Ilaria Attili, Alberto Ranghiero, Giulio Cammarata, Marta Minotti, Giuliana Lo Presti, Francesca De Piano, Federica Bellerba, Gianluigi Funicelli, Stefania Volpe, Serena Mora, Cristiana Fodor, Cristiano Rampinelli, Massimo Barberis, Filippo De Marinis, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Stefania Rizzo, Francesca Bot |
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy. Thoracic cancer 2023 9 . Yoshiaki Amino, Siew-Kee Low, Hironori Ninomiya, Ayu Kiritani, Keiki Miyadera, Sho Kakuto, Takahiro Akita, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nish |
Path less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer. JCO oncology practice 2023 9 OP2300273. Sun Min Lim, Jii Bum Lee, Yuko Oya, Jorn Nutzinger, Ross S |
The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer research communications 2023 9 . Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Narayan, Clifford G Robinson, Vivek S Kavadi, Joel S Greenberger, Christopher D Koprowski, James W Welsh, Elizabeth Gore, Robert M MacRae, Rebecca Paulus, Jeffrey Bradl |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals. European journal of medical research 2023 11 28 (1): 478. Jing Ren, Yuan Wang, Chunrong Liu, Lan Yang, Xinlu Men, Zhixin Q |
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations. Cancers 2023 11 15 (22): . Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Ju |
Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C. Frontiers in oncology 2023 11 13 1239000. Lucía Notario, Marc Cucurull, Gabriela Cerdà, Carolina Sanz, Enric Carcereny, Ana Muñoz-Mármol, Ainhoa Hernández, Marta Domènech, Teresa Morán, Montse Sánchez-Céspedes, Marta Costa, Jose-Luis Mate, Anna Esteve, Maria Sai |
Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis. medRxiv : the preprint server for health sciences 2023 11 . Cheng Chen, Michael P Douglas, Meera V Ragavan, Kathryn A Phillips, Jeroen P Jans |
Efficacy and toxicity of drugs targeting KRAS mutation in non-small cell lung cancer: a meta-analysis. Expert review of anticancer therapy 2023 11 . Wei Luo, Jing Zhu, Wenxue Zhang, Airu Yu, Wei Zhou, Ke |
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer cell 2023 10 . Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, Jian Carrot-Zha |
Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Diagnostics (Basel, Switzerland) 2023 10 13 (19): . Durgesh Wankhede, Christophe Bontoux, Sandeep Grover, Paul Hofm |
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer. Clinical Medicine Insights. Oncology 2023 10 17 11795549231184918. Lihuan Zhu, Dongsheng Zhou, Yiyong Chen, Tianxing Guo, Wenshu Chen, Xiaojie P |
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort. Tumori 2023 10 3008916231204441. Andrea Olsen, Alexandra Lebedeva, Polina Nosova, Vladislav Nikulin, Margarita Sharova, Ekaterina Ignatova, Vladislav Mileyko, Maxim Ivan |
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT). Clinical lung cancer 2024 5 . Andrew Fantoni, Lydia Warburton, Benjamin Solomon, Marliese Alexander, Meghana Maddula, Lauren Julia Brown, Ines Pires da Silva, Adnan Nagrial, Farah Abu Al-Hial, Malinda Itchins, Nick Pavlakis, Samantha Bowy |
Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis. JCO global oncology 2024 4 10 e2300379. Thomas Knapp, Joseph Nygaard, Joshua Cassinat, Fernando Galvez, Priya K Gopal |
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ke Wang, Manyi Xu, Yanhua Wang, Chunwei Xu, Yue Hao, Zhengbo So |
Clinical utility of circulating tumor DNA in patients with advanced KRAS-mutated non-small cell lung cancer treated with sotorasib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 4 . Sophie M Ernst, Ronald van Marion, Peggy N Atmodimedjo, Evert de Jonge, Ron H J Mathijssen, Marthe S Paats, Peter de Bruijn, Stijn L Koolen, Jan H von der Thüsen, Joachim G J V Aerts, Ron H N van Schaik, Hendrikus J Dubbink, Anne-Marie C Dingema |
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers 2024 4 16 (7): . Rossella Bruno, Anello Marcello Poma, Martina Panozzi, Alessandra Lenzini, Gianmarco Elia, Carmelina Cristina Zirafa, Vittorio Aprile, Marcello Carlo Ambrogi, Editta Baldini, Marco Lucchi, Franca Melfi, Antonio Chella, Andrea Sbrana, Greta A |
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation. Clinical lung cancer 2024 1 . Adam Barsouk, Cole Friedes, Michelle Iocolano, Abigail Doucette, Roger B Cohen, Kyle W Robinson, Christopher A D'Avella, Melina E Marmarelis, John A Kosteva, Aditi P Singh, Christine A Ciunci, William P Levin, Keith A Cengel, Jeffrey D Bradley, Steven J Feigenberg, Lova Sun, Charu Aggarwal, Corey J Langer, Nikhil Yegya-Ram |
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 1 191 110082. Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zha |
[Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lung and its associated lung cancer in adults]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 1 53 (2): 130-135. L Liang, C Y Wu, L P Zhang, L K Hou, Z W Dong, W Wu, Y Huang, H K X |
RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco. Cancer control : journal of the Moffitt Cancer Center 2024 1 31 10732748241229290. Fatima El Agy, Sanae El Bardai, Sara Boukansa, Laila Bouguenouch, Zineb Benbrahim, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Karim Ouldim, Sidi Adil Ibrahimi, Laila Chba |
KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges. Pathology oncology research : POR 2024 1 29 1611580. Judit Moldvay, József Tím |
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: